Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage
Go back to Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage| (NASDAQ: ERNA) | Delayed: 4.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.31 | 52 Week High | $ | |||
| Open | $4.31 | 52 Week Low | $ | |||
| Day High | $4.31 | P/E | N/A | |||
| Day Low | $4.31 | EPS | $ | |||
| Volume | 11 | |||||
| (NASDAQ: ERNA) | Delayed: 4.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.31 | 52 Week High | $ | |||
| Open | $4.31 | 52 Week Low | $ | |||
| Day High | $4.31 | P/E | N/A | |||
| Day Low | $4.31 | EPS | $ | |||
| Volume | 11 | |||||
| RYDEX 2X S&P SELECT SECTOR FINANCIAL ETF (NYSE: RFL) | Delayed: 2.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.56 | 52 Week High | $17.54 | |||
| Open | $2.56 | 52 Week Low | $0.15 | |||
| Day High | $2.56 | P/E | N/A | |||
| Day Low | $2.56 | EPS | $0.00 | |||
| Volume | 5,636 | |||||

